Table 5.
Independent variables | Number (%) | Unadjusted | Adjusted | ||
---|---|---|---|---|---|
OR | 95% CI | OR | 95% CI | ||
Age-2 (years, mean ± SD) | 47.6 ± 9.6 | 0.99 | 0.97–1.01 | 1.01 | 0.98–1.03 |
| |||||
ART regimen | |||||
Second- or third-line | 208 (39.2) | 1† | — | 1† | — |
First-line | 323 (60.8) | 1.2 | 0.86–1.74 | 1.22 | 0.82–1.79 |
| |||||
Duration of exposure (months, mean ± SD) | 84.9 ± 29.7 | 0.95 | 0.88–1.02 | 0.95 | 0.85–1.02 |
| |||||
Gender | |||||
Male | 163 (30.7) | 1† | — | 1† | — |
Female | 368 (69.3) | 3.00∗∗ | 2.00–4.45 | 2.84∗∗ | 1.83–4.42 |
| |||||
CD4 cell count/mm3 | |||||
≥ 350 | 421 (79.3) | 1† | — | 1† | — |
201-249 | 76 (14.3) | 0.27∗∗ | 0.15–0.48 | 0.38∗ | 0.16–0.89 |
Nadir (0–200) | 34 (6.4) | 0.29∗∗ | 0.13–0.66 | 0.30∗∗ | 0.17–0.55 |
| |||||
DRC | |||||
Absent | 442 (83.2) | 1† | — | 1† | — |
Present | 89 (16.8) | 1.88∗∗ | 1.18–2.98 | 2.2∗∗ | 1.18–3.39 |
Age-2 = age at the last clinic visit; ART = antiretroviral therapy; DRC = diabetes-related comorbidity; OR = odd ratio; CI = confidence interval; ∗p < 0.05; ∗∗p < 0.001; Cox and Snell R2 = 0.12; Hosmer and Lemeshow p = 0.14; †reference group.